Early detection of Parkinson’s disease can vastly improve outcomes. Prof. Tiago Outiero (University Medical Center Goettingen, Goettingen, Germany) discussed with touchNEUROLOGY his research combining basic science to use biological markers and clinical signs to diagnose Parkinson’s disease.
Questions:
- Why is early detection of Parkinson’s disease essential, and what are the current challenges in achieving this? (00:15)
- Tell us about your approach, which combines aspects of basic science to use biological markers alongside clinical signs to help diagnose Parkinson’s disease. (01:10)
- What have you learned from this approach as applied in other areas of neurological disease? (02:37)
- How do you think these principles should be incorporated into routine practice to help diagnose disease sooner? (03:48)
The session entitled ‘Biological vs Clinical Diagnosis of Parkinson’s disease’ took place at the European Academy of Neurology Congress 2022, 25–28 June 2022.
Disclosure: Tiago Outiero has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Lisa Glass.
Filmed as a highlight of EAN 2022.
